Zyclara (imiquimod) - Mochida, Viatris, Bausch Health
IDH1R132H peptide vaccine - German Cancer Research Center
temozolomide - Generic mfg.
STAR-VACC: IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas (clinicaltrials.gov) - Oct 23, 2026 - P2 | N=216 | Not yet recruiting | Sponsor: German Cancer Research Center 
First-in-human • New P2 trial • Anaplastic Astrocytoma • Astrocytoma • Brain Cancer • Glioblastoma • Oncology • Solid Tumor • ATRX
http://clinicaltrials.gov/ct2/show/NCT07888647
 
Oct 23, 2026
 
Next